Discordant EGFR mutation results: A case report
Background: Epidermal growth factor receptor (EGFR) is one of the driver mutations in advanced Non – Small Cell Lung Carcinoma (NSCLC) and is prominently chosen to advocate personalized treatment approaches. The advancing field of molecular pathology along with the introduction of the EGFR TKIs has...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-09-01
|
Series: | Human Pathology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772736X22000779 |